Participation in NCBiR project

2017-11-15 01:00

BioResearch took part in and won a tender for new, innovative clinical study with esketamine, sponsored by Celon Pharma S.A. Due to our experience, engagement and professional approach, our offer was the most attractive and well-prepared.

The study will begin in December, the clinical part will be conducted in our Site in Kajetany.

Go back

News

2020-04-17 11:55

FDA and EMEA guidelines during a pandemic.

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

2020-03-24 10:05

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic..

2020-03-23 14:10

BRG update on COVID-19

Dear Investigators and Researchers.
In recent days, the whole world is providing heroic fight with the SARS-CoV-2 virus.

International Clinical Trials Day

On 28th of June, 2019 we attended the annual conference on the occassion of International Clinical Trials Day titled "On the verge of changes".

2019-05-31 11:28

TransCelerate accreditation

To improve our trainings system, we joined „GCP Mutual Recognition Program" and were accredited by TransCelerate Biopharma Inc.

Read more … TransCelerate accreditation

Page 6 of 10